Literature DB >> 25244574

Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.

David Bonekamp1,2, Katerina Deike1, Benedikt Wiestler3,4, Wolfgang Wick3,4, Martin Bendszus1, Alexander Radbruch1,4, Sabine Heiland2.   

Abstract

BACKGROUND: To compare intraindividual dynamic susceptibility contrast (DSC) and dynamic contrast enhanced (DCE) MR perfusion parameters and determine the association of DCE parameters with overall survival (OS) with the established predictive DSC parameter cerebral blood volume (CBV) in patients with newly diagnosed glioblastoma.
METHODS: Perfusion data were analyzed retrospectively, and included scans performed preoperatively at 3.0 Tesla in 37 patients (25 males, 12 females, 39-83 years, median 65) later diagnosed with glioblastoma. All patients received standard treatment consisting of surgery and radiochemotherapy. Images were spatially coregistered and maximum region of interest-based DCE and DSC parameter measurements compared and thresholds identified using multivariate linear regression, Pearson's correlation coefficients and using receiver operating characteristic analysis. Survival analysis was performed using Kaplan-Meier curves.
RESULTS: While both, elevated volume transfer constant (K(trans) ) (>0.29 min(-1) ; P = 0.041) and CBV (>23.7 mL/100 mL; P < 0.001) were significantly associated with OS, elevated CBV was associated with worse OS compared with elevated K(trans) . K(trans) was significantly correlated with the leakage correction factor K2 but not with CBV.
CONCLUSION: The combined use of DSC and DCE MR perfusion may provide additional information of prognostic value for glioblastoma patient survival prediction. As K(trans) was not tightly coupled to CBV, both parameters may reflect different stages in the pathogenetic sequence of glioblastoma growth.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  cerebral blood volume; dynamic contrast enhanced MRI; dynamic susceptibility contrast MRI; glioblastoma; magnetic resonance imaging; overall survival; perfusion imaging; volume transfer constant

Mesh:

Substances:

Year:  2014        PMID: 25244574     DOI: 10.1002/jmri.24756

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  31 in total

Review 1.  Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.

Authors:  Mark S Shiroishi; Jerrold L Boxerman; Whitney B Pope
Journal:  Neuro Oncol       Date:  2015-09-12       Impact factor: 12.300

2.  Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.

Authors:  Daniel Paech; Constantin Dreher; Sebastian Regnery; Jan-Eric Meissner; Steffen Goerke; Johannes Windschuh; Johanna Oberhollenzer; Miriam Schultheiss; Katerina Deike-Hofmann; Sebastian Bickelhaupt; Alexander Radbruch; Moritz Zaiss; Andreas Unterberg; Wolfgang Wick; Martin Bendszus; Peter Bachert; Mark E Ladd; Heinz-Peter Schlemmer
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

3.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.

Authors:  Luke Macyszyn; Hamed Akbari; Jared M Pisapia; Xiao Da; Mark Attiah; Vadim Pigrish; Yingtao Bi; Sharmistha Pal; Ramana V Davuluri; Laura Roccograndi; Nadia Dahmane; Maria Martinez-Lage; George Biros; Ronald L Wolf; Michel Bilello; Donald M O'Rourke; Christos Davatzikos
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 12.300

4.  Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.

Authors:  Sina Burth; Philipp Kickingereder; Oliver Eidel; Diana Tichy; David Bonekamp; Lukas Weberling; Antje Wick; Sarah Löw; Anne Hertenstein; Martha Nowosielski; Heinz-Peter Schlemmer; Wolfgang Wick; Martin Bendszus; Alexander Radbruch
Journal:  Neuro Oncol       Date:  2016-06-13       Impact factor: 12.300

5.  High-resolution whole-brain DCE-MRI using constrained reconstruction: Prospective clinical evaluation in brain tumor patients.

Authors:  Yi Guo; R Marc Lebel; Yinghua Zhu; Sajan Goud Lingala; Mark S Shiroishi; Meng Law; Krishna Nayak
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

6.  Diffuse microvascular dysfunction and loss of white matter integrity predict poor outcomes in patients with acute ischemic stroke.

Authors:  Natalia S Rost; Pedro Cougo; Svetlana Lorenzano; Hua Li; Lisa Cloonan; Mark Jrj Bouts; Arne Lauer; Mark R Etherton; Hasan H Karadeli; Patricia L Musolino; William A Copen; Ken Arai; Eng H Lo; Steve K Feske; Karen L Furie; Ona Wu
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-08       Impact factor: 6.200

7.  Integrated Biophysical Modeling and Image Analysis: Application to Neuro-Oncology.

Authors:  Andreas Mang; Spyridon Bakas; Shashank Subramanian; Christos Davatzikos; George Biros
Journal:  Annu Rev Biomed Eng       Date:  2020-06-04       Impact factor: 9.590

8.  Overall survival prediction in glioblastoma patients using structural magnetic resonance imaging (MRI): advanced radiomic features may compensate for lack of advanced MRI modalities.

Authors:  Spyridon Bakas; Gaurav Shukla; Hamed Akbari; Guray Erus; Aristeidis Sotiras; Saima Rathore; Chiharu Sako; Sung Min Ha; Martin Rozycki; Russell T Shinohara; Michel Bilello; Christos Davatzikos
Journal:  J Med Imaging (Bellingham)       Date:  2020-06-09

9.  Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.

Authors:  Spyridon Bakas; Hamed Akbari; Aristeidis Sotiras; Michel Bilello; Martin Rozycki; Justin S Kirby; John B Freymann; Keyvan Farahani; Christos Davatzikos
Journal:  Sci Data       Date:  2017-09-05       Impact factor: 6.444

10.  The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.

Authors:  Y S Choi; D W Kim; S-K Lee; J H Chang; S-G Kang; E H Kim; S H Kim; T H Rim; S S Ahn
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.